Here’s What Analysts Are Saying About Bristol-Myers Squibb Company (BMY)

1 day ago 4

Noor Ul Ain Rehman

Fri, February 13, 2026 astatine 8:57 AM CST 2 min read

Bristol-Myers Squibb Company (NYSE:BMY) is 1 of the champion aesculapian probe stocks to bargain according to hedge funds. Bernstein reiterated its Hold standing connected Bristol-Myers Squibb Company (NYSE:BMY) connected February 10 and acceptable a terms people of $58.00. Bristol-Myers Squibb Company (NYSE:BMY) besides received a standing update from Morgan Stanley connected February 6, which lifted the terms people connected the banal to $40 from $37 portion keeping an Underweight standing connected the shares. The steadfast told investors successful a probe enactment that portion the 2026 gross and EPS guidance exceeded consensus, it was driven by a higher-than-expected Eliquis guide.

Citi Raises Bristol-Myers (BMY) Target arsenic Sector Outlook Improves into 2026

In summation to Morgan Stanley, BofA besides raised the terms people connected Bristol-Myers Squibb Company (NYSE:BMY) to $68 from $64 connected February 6 and maintained a Buy standing connected the shares. The steadfast lifted its near-term forecasts aft the institution delivered fiscal Q4 and FY26 guidance beats, telling investors that Bristol-Myers Squibb Company (NYSE:BMY) “is a pipeline story”.

The aforesaid day, Guggenheim besides raised the terms people connected the banal to $72 from $62, maintaining a Buy standing connected the shares and raising its presumption of the likelihood of occurrence to 90% for iber/mezi from the erstwhile 33%. The steadfast besides accrued its presumption of the likelihood of occurrence to 90% from 75% anterior for milvexian successful SSP, stating that it is continuing to urge that investors bargain shares up of the company’s “series of high-profile, perchance high-reward” Phase 3 catalysts.

Bristol-Myers Squibb Company (NYSE:BMY) is simply a biopharmaceutical institution that discovers, develops, and delivers precocious medicines for superior diseases. Its medicines autumn into assorted therapeutic classes, including hematology, oncology, cardiovascular, immunology, and neuroscience.

While we admit the imaginable of BMY arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published at Insider Monkey.

Read Entire Article